▶ 調査レポート

世界の発現用コンピテントセル市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Expressed Competent Cells Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の発現用コンピテントセル市場規模・現状・予測(2021年-2027年) / Global Expressed Competent Cells Market Size, Status and Forecast 2021-2027 / QYR2104Z2276資料のイメージです。• レポートコード:QYR2104Z2276
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、131ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥546,000 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥819,000 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,092,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、発現用コンピテントセルのグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(20 *100μl、50 *100μl、100 *100μl、その他)、用途別市場規模(タンパク質発現、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・発現用コンピテントセルの市場動向
・企業の競争状況、市場シェア
・発現用コンピテントセルの種類別市場規模(20 *100μl、50 *100μl、100 *100μl、その他)
・発現用コンピテントセルの用途別市場規模(タンパク質発現、その他)
・発現用コンピテントセルの北米市場規模2016-2027(アメリカ、カナダ)
・発現用コンピテントセルのヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・発現用コンピテントセルのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・発現用コンピテントセルの中南米市場規模2016-2027(メキシコ、ブラジル)
・発現用コンピテントセルの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Merck KGaA、Thermo Fisher Scientific、Agilent Technologies、Takara Bio、Promega Corporation、Beijing TransGen Biotech、GeneScript Corporation、Yeastern Biotech、New England Biolabs、QIAGEN N.V.、OriGene Technologies、Lucigen、Zymo Research、Bio-Rad Laboratories、Bioline)
・結論

Expressed Competent cells are bacterial cells that can accept extra-chromosomal DNA or plasmids (naked DNA) from the environment. … Bacteria can also be made competent artificially by chemical treatment and heat shock to make them transiently permeable to DNA.

Market Analysis and Insights: Global Expressed Competent Cells Market
The global Expressed Competent Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Expressed Competent Cells market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Expressed Competent Cells market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Expressed Competent Cells market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Expressed Competent Cells market.

Global Expressed Competent Cells Scope and Market Size
Expressed Competent Cells market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Expressed Competent Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
20*100μl
50*100μl
100*100μl
Other

Segment by Application
Protein Expression
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
Takara Bio
Promega Corporation
Lucigen
Zymo Research

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Expressed Competent Cells Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 20*100μl
1.2.3 50*100μl
1.2.4 100*100μl
1.2.5 Other
1.3 Market by Application
1.3.1 Global Expressed Competent Cells Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Protein Expression
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Expressed Competent Cells Market Perspective (2016-2027)
2.2 Expressed Competent Cells Growth Trends by Regions
2.2.1 Expressed Competent Cells Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Expressed Competent Cells Historic Market Share by Regions (2016-2021)
2.2.3 Expressed Competent Cells Forecasted Market Size by Regions (2022-2027)
2.3 Expressed Competent Cells Industry Dynamic
2.3.1 Expressed Competent Cells Market Trends
2.3.2 Expressed Competent Cells Market Drivers
2.3.3 Expressed Competent Cells Market Challenges
2.3.4 Expressed Competent Cells Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Expressed Competent Cells Players by Revenue
3.1.1 Global Top Expressed Competent Cells Players by Revenue (2016-2021)
3.1.2 Global Expressed Competent Cells Revenue Market Share by Players (2016-2021)
3.2 Global Expressed Competent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Expressed Competent Cells Revenue
3.4 Global Expressed Competent Cells Market Concentration Ratio
3.4.1 Global Expressed Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Expressed Competent Cells Revenue in 2020
3.5 Expressed Competent Cells Key Players Head office and Area Served
3.6 Key Players Expressed Competent Cells Product Solution and Service
3.7 Date of Enter into Expressed Competent Cells Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Expressed Competent Cells Breakdown Data by Type
4.1 Global Expressed Competent Cells Historic Market Size by Type (2016-2021)
4.2 Global Expressed Competent Cells Forecasted Market Size by Type (2022-2027)

5 Expressed Competent Cells Breakdown Data by Application
5.1 Global Expressed Competent Cells Historic Market Size by Application (2016-2021)
5.2 Global Expressed Competent Cells Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Expressed Competent Cells Market Size (2016-2027)
6.2 North America Expressed Competent Cells Market Size by Type
6.2.1 North America Expressed Competent Cells Market Size by Type (2016-2021)
6.2.2 North America Expressed Competent Cells Market Size by Type (2022-2027)
6.2.3 North America Expressed Competent Cells Market Size by Type (2016-2027)
6.3 North America Expressed Competent Cells Market Size by Application
6.3.1 North America Expressed Competent Cells Market Size by Application (2016-2021)
6.3.2 North America Expressed Competent Cells Market Size by Application (2022-2027)
6.3.3 North America Expressed Competent Cells Market Size by Application (2016-2027)
6.4 North America Expressed Competent Cells Market Size by Country
6.4.1 North America Expressed Competent Cells Market Size by Country (2016-2021)
6.4.2 North America Expressed Competent Cells Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Expressed Competent Cells Market Size (2016-2027)
7.2 Europe Expressed Competent Cells Market Size by Type
7.2.1 Europe Expressed Competent Cells Market Size by Type (2016-2021)
7.2.2 Europe Expressed Competent Cells Market Size by Type (2022-2027)
7.2.3 Europe Expressed Competent Cells Market Size by Type (2016-2027)
7.3 Europe Expressed Competent Cells Market Size by Application
7.3.1 Europe Expressed Competent Cells Market Size by Application (2016-2021)
7.3.2 Europe Expressed Competent Cells Market Size by Application (2022-2027)
7.3.3 Europe Expressed Competent Cells Market Size by Application (2016-2027)
7.4 Europe Expressed Competent Cells Market Size by Country
7.4.1 Europe Expressed Competent Cells Market Size by Country (2016-2021)
7.4.2 Europe Expressed Competent Cells Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Expressed Competent Cells Market Size (2016-2027)
8.2 Asia-Pacific Expressed Competent Cells Market Size by Type
8.2.1 Asia-Pacific Expressed Competent Cells Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Expressed Competent Cells Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Expressed Competent Cells Market Size by Type (2016-2027)
8.3 Asia-Pacific Expressed Competent Cells Market Size by Application
8.3.1 Asia-Pacific Expressed Competent Cells Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Expressed Competent Cells Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Expressed Competent Cells Market Size by Application (2016-2027)
8.4 Asia-Pacific Expressed Competent Cells Market Size by Region
8.4.1 Asia-Pacific Expressed Competent Cells Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Expressed Competent Cells Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Expressed Competent Cells Market Size (2016-2027)
9.2 Latin America Expressed Competent Cells Market Size by Type
9.2.1 Latin America Expressed Competent Cells Market Size by Type (2016-2021)
9.2.2 Latin America Expressed Competent Cells Market Size by Type (2022-2027)
9.2.3 Latin America Expressed Competent Cells Market Size by Type (2016-2027)
9.3 Latin America Expressed Competent Cells Market Size by Application
9.3.1 Latin America Expressed Competent Cells Market Size by Application (2016-2021)
9.3.2 Latin America Expressed Competent Cells Market Size by Application (2022-2027)
9.3.3 Latin America Expressed Competent Cells Market Size by Application (2016-2027)
9.4 Latin America Expressed Competent Cells Market Size by Country
9.4.1 Latin America Expressed Competent Cells Market Size by Country (2016-2021)
9.4.2 Latin America Expressed Competent Cells Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Expressed Competent Cells Market Size (2016-2027)
10.2 Middle East & Africa Expressed Competent Cells Market Size by Type
10.2.1 Middle East & Africa Expressed Competent Cells Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Expressed Competent Cells Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Expressed Competent Cells Market Size by Type (2016-2027)
10.3 Middle East & Africa Expressed Competent Cells Market Size by Application
10.3.1 Middle East & Africa Expressed Competent Cells Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Expressed Competent Cells Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Expressed Competent Cells Market Size by Application (2016-2027)
10.4 Middle East & Africa Expressed Competent Cells Market Size by Country
10.4.1 Middle East & Africa Expressed Competent Cells Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Expressed Competent Cells Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Expressed Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Expressed Competent Cells Business (2016-2021)
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Expressed Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Expressed Competent Cells Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Expressed Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Expressed Competent Cells Business (2016-2021)
11.3.5 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Expressed Competent Cells Introduction
11.4.4 Takara Bio Revenue in Expressed Competent Cells Business (2016-2021)
11.4.5 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Expressed Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Expressed Competent Cells Business (2016-2021)
11.5.5 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Expressed Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Expressed Competent Cells Business (2016-2021)
11.6.5 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Expressed Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Expressed Competent Cells Business (2016-2021)
11.7.5 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Expressed Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Expressed Competent Cells Business (2016-2021)
11.8.5 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Expressed Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Expressed Competent Cells Business (2016-2021)
11.9.5 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Expressed Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Expressed Competent Cells Business (2016-2021)
11.10.5 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Expressed Competent Cells Introduction
11.11.4 OriGene Technologies Revenue in Expressed Competent Cells Business (2016-2021)
11.11.5 OriGene Technologies Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Expressed Competent Cells Introduction
11.12.4 Lucigen Revenue in Expressed Competent Cells Business (2016-2021)
11.12.5 Lucigen Recent Development
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Expressed Competent Cells Introduction
11.13.4 Zymo Research Revenue in Expressed Competent Cells Business (2016-2021)
11.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Expressed Competent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Expressed Competent Cells Business (2016-2021)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Expressed Competent Cells Introduction
11.15.4 Bioline Revenue in Expressed Competent Cells Business (2016-2021)
11.15.5 Bioline Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Expressed Competent Cells Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 20*100μl
Table 3. Key Players of 50*100μl
Table 4. Key Players of 100*100μl
Table 5. Key Players of Other
Table 6. Global Expressed Competent Cells Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Expressed Competent Cells Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Expressed Competent Cells Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Expressed Competent Cells Market Share by Regions (2016-2021)
Table 10. Global Expressed Competent Cells Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Expressed Competent Cells Market Share by Regions (2022-2027)
Table 12. Expressed Competent Cells Market Trends
Table 13. Expressed Competent Cells Market Drivers
Table 14. Expressed Competent Cells Market Challenges
Table 15. Expressed Competent Cells Market Restraints
Table 16. Global Expressed Competent Cells Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Expressed Competent Cells Market Share by Players (2016-2021)
Table 18. Global Top Expressed Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Expressed Competent Cells as of 2020)
Table 19. Ranking of Global Top Expressed Competent Cells Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Expressed Competent Cells Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Expressed Competent Cells Product Solution and Service
Table 23. Date of Enter into Expressed Competent Cells Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Expressed Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Expressed Competent Cells Revenue Market Share by Type (2016-2021)
Table 27. Global Expressed Competent Cells Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Expressed Competent Cells Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Expressed Competent Cells Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Expressed Competent Cells Revenue Market Share by Application (2016-2021)
Table 31. Global Expressed Competent Cells Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Expressed Competent Cells Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Expressed Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Expressed Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Expressed Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Expressed Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Expressed Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Expressed Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Expressed Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Expressed Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Expressed Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Expressed Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Expressed Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Expressed Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Expressed Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Expressed Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Expressed Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Expressed Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Expressed Competent Cells Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Expressed Competent Cells Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Expressed Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Expressed Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Expressed Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Expressed Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Expressed Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Expressed Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Expressed Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Expressed Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Expressed Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Expressed Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Expressed Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Expressed Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck KGaA Company Details
Table 64. Merck KGaA Business Overview
Table 65. Merck KGaA Expressed Competent Cells Product
Table 66. Merck KGaA Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 67. Merck KGaA Recent Development
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Expressed Competent Cells Product
Table 71. Thermo Fisher Scientific Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. Agilent Technologies Company Details
Table 74. Agilent Technologies Business Overview
Table 75. Agilent Technologies Expressed Competent Cells Product
Table 76. Agilent Technologies Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 77. Agilent Technologies Recent Development
Table 78. Takara Bio Company Details
Table 79. Takara Bio Business Overview
Table 80. Takara Bio Expressed Competent Cells Product
Table 81. Takara Bio Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 82. Takara Bio Recent Development
Table 83. Promega Corporation Company Details
Table 84. Promega Corporation Business Overview
Table 85. Promega Corporation Expressed Competent Cells Product
Table 86. Promega Corporation Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 87. Promega Corporation Recent Development
Table 88. Beijing TransGen Biotech Company Details
Table 89. Beijing TransGen Biotech Business Overview
Table 90. Beijing TransGen Biotech Expressed Competent Cells Product
Table 91. Beijing TransGen Biotech Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 92. Beijing TransGen Biotech Recent Development
Table 93. GeneScript Corporation Company Details
Table 94. GeneScript Corporation Business Overview
Table 95. GeneScript Corporation Expressed Competent Cells Product
Table 96. GeneScript Corporation Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 97. GeneScript Corporation Recent Development
Table 98. Yeastern Biotech Company Details
Table 99. Yeastern Biotech Business Overview
Table 100. Yeastern Biotech Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 101. Yeastern Biotech Recent Development
Table 102. New England Biolabs Company Details
Table 103. New England Biolabs Business Overview
Table 104. New England Biolabs Expressed Competent Cells Product
Table 105. New England Biolabs Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 106. New England Biolabs Recent Development
Table 107. QIAGEN N.V. Company Details
Table 108. QIAGEN N.V. Business Overview
Table 109. QIAGEN N.V. Expressed Competent Cells Product
Table 110. QIAGEN N.V. Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 111. QIAGEN N.V. Recent Development
Table 112. OriGene Technologies Company Details
Table 113. OriGene Technologies Business Overview
Table 114. OriGene Technologies Expressed Competent Cells Product
Table 115. OriGene Technologies Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 116. OriGene Technologies Recent Development
Table 117. Lucigen Company Details
Table 118. Lucigen Business Overview
Table 119. Lucigen Expressed Competent Cells Product
Table 120. Lucigen Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 121. Lucigen Recent Development
Table 122. Zymo Research Company Details
Table 123. Zymo Research Business Overview
Table 124. Zymo Research Expressed Competent Cells Product
Table 125. Zymo Research Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 126. Zymo Research Recent Development
Table 127. Bio-Rad Laboratories Company Details
Table 128. Bio-Rad Laboratories Business Overview
Table 129. Bio-Rad Laboratories Expressed Competent Cells Product
Table 130. Bio-Rad Laboratories Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 131. Bio-Rad Laboratories Recent Development
Table 132. Bioline Company Details
Table 133. Bioline Business Overview
Table 134. Bioline Expressed Competent Cells Product
Table 135. Bioline Revenue in Expressed Competent Cells Business (2016-2021) & (US$ Million)
Table 136. Bioline Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Expressed Competent Cells Market Share by Type: 2020 VS 2027
Figure 2. 20*100μl Features
Figure 3. 50*100μl Features
Figure 4. 100*100μl Features
Figure 5. Other Features
Figure 6. Global Expressed Competent Cells Market Share by Application: 2020 VS 2027
Figure 7. Protein Expression Case Studies
Figure 8. Other Case Studies
Figure 9. Expressed Competent Cells Report Years Considered
Figure 10. Global Expressed Competent Cells Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Expressed Competent Cells Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Expressed Competent Cells Market Share by Regions: 2020 VS 2027
Figure 13. Global Expressed Competent Cells Market Share by Regions (2022-2027)
Figure 14. Global Expressed Competent Cells Market Share by Players in 2020
Figure 15. Global Top Expressed Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Expressed Competent Cells as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Expressed Competent Cells Revenue in 2020
Figure 17. Global Expressed Competent Cells Revenue Market Share by Type (2016-2021)
Figure 18. Global Expressed Competent Cells Revenue Market Share by Type (2022-2027)
Figure 19. North America Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Expressed Competent Cells Market Share by Type (2016-2027)
Figure 21. North America Expressed Competent Cells Market Share by Application (2016-2027)
Figure 22. North America Expressed Competent Cells Market Share by Country (2016-2027)
Figure 23. United States Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Expressed Competent Cells Market Share by Type (2016-2027)
Figure 27. Europe Expressed Competent Cells Market Share by Application (2016-2027)
Figure 28. Europe Expressed Competent Cells Market Share by Country (2016-2027)
Figure 29. Germany Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Expressed Competent Cells Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Expressed Competent Cells Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Expressed Competent Cells Market Share by Region (2016-2027)
Figure 39. China Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Expressed Competent Cells Market Share by Type (2016-2027)
Figure 47. Latin America Expressed Competent Cells Market Share by Application (2016-2027)
Figure 48. Latin America Expressed Competent Cells Market Share by Country (2016-2027)
Figure 49. Mexico Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Expressed Competent Cells Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Expressed Competent Cells Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Expressed Competent Cells Market Share by Country (2016-2027)
Figure 55. Turkey Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Expressed Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Merck KGaA Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 60. Agilent Technologies Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 61. Takara Bio Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 62. Promega Corporation Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 63. Beijing TransGen Biotech Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 64. GeneScript Corporation Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 65. Yeastern Biotech Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 66. New England Biolabs Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 67. QIAGEN N.V. Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 68. OriGene Technologies Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 69. Lucigen Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 70. Zymo Research Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 71. Bio-Rad Laboratories Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 72. Bioline Revenue Growth Rate in Expressed Competent Cells Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed